Barclays raised the firm’s price target on RadNet (RDNT) to $85 from $79 and keeps an Overweight rating on the shares. The firm walked away from the RSNA Conference with a greater appreciation for the ...
RadNet's latest collaboration aims to create an AI control system for image interpretation to ensure AI scalability, performance monitoring and safety.
RadNet, Inc. RDNT yesterday announced that its wholly-owned subsidiary, DeepHealth, Inc., has partnered with artificial intelligence (AI) orchestration company, CARPL.ai. The collaboration aims to ...
Jefferies analyst Brian Tanquilut raised the firm’s price target on RadNet (RDNT) to $100 from $82 and keeps a Buy rating on the shares. Ongoing strength in broader healthcare utilization, along with ...